Page last updated: 2024-09-02

ecteinascidin 743 and Hereditary Breast and Ovarian Cancer Syndrome

ecteinascidin 743 has been researched along with Hereditary Breast and Ovarian Cancer Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aracil, M; D'Incalci, M; Italiano, A; Kaye, SB; Lorusso, D; Monk, BJ; Tanović, A	1

Reviews

1 review(s) available for ecteinascidin 743 and Hereditary Breast and Ovarian Cancer Syndrome

Article	Year
Trabectedin as a chemotherapy option for patients with BRCA deficiency. Cancer treatment reviews, 2016, Volume: 50 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Dioxoles; Doxorubicin; Female; Genes, BRCA1; Genes, BRCA2; Hereditary Breast and Ovarian Cancer Syndrome; Humans; Ovarian Neoplasms; Polyethylene Glycols; Sarcoma; Tetrahydroisoquinolines; Trabectedin	2016

Article

Year

Trabectedin as a chemotherapy option for patients with BRCA deficiency.

Cancer treatment reviews, 2016, Volume: 50

Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Dioxoles; Doxorubicin; Female; Genes, BRCA1; Genes, BRCA2; Hereditary Breast and Ovarian Cancer Syndrome; Humans; Ovarian Neoplasms; Polyethylene Glycols; Sarcoma; Tetrahydroisoquinolines; Trabectedin

2016